Ms. Najla Guthrie, President/CEO is an internationally recognized scientist in the field of nutrition and breast cancer. Her research conducted at the Centre for Human Nutrition, University of Western Ontario, focused on anti-cancer effects of citrus juices and their constituent flavonoids and continues to generate scientific and media interest. Ms. Guthrie has published over 50 papers in peer-reviewed journals and has given numerous invited presentations at national and international scientific and industry events. A founding shareholder, Ms. Guthrie successfully transitioned from a nutraceutical medicines researcher to President and CEO of KGK Science. Under her leadership, KGK Science has established and executed on, a strategic plan to leverage its research infrastructure and generate sufficient capital to finance the development of new and patented nutraceutical product groups of its own. She is responsible for the co-development of Diabetinol™ and Dermytol™ and for the commercialization and licensing of KGK’s cholesterol reduction product, Sytrinol™. Ms. Guthrie has led and managed the Company’s growth of its contract research business over the past 22 years and has been responsible for recruitment of an integrated research and product development team that today maintains a reputation for world-class nutraceutical science with an emerging expertise in cannabis research. Currently, Ms. Guthrie is known as a spokesperson and global leader in the nutraceutical industry and continues to lobby for the advancement of regulations and policy changes better suited for the supplement and cannabis industry.